Skip to main content
Investigative Ebola treatments cleared for shipment to Uganda
6/19/2019

Uganda had allowed the use of three investigational treatments for Ebola virus infection from Mapp Biopharmaceutical, Gilead Sciences and Regeneron Pharmaceuticals. In the Democratic Republic of Congo, 2,087 cases have now been confirmed and another 322 suspected cases are being evaluated.

Full Story: